Dimensional Fund Advisors LP has recently announced that it has increased stake in Invesco Ltd (NYSE:IVZ) by 17.18%. After grabbing 11.21 million shares, the institutional investor is now in possession of 1.64 million shares of the Financial Company. The new investment brought the stake of investor firm to 2.49% having worth around $159.91 million. Moreover, Geode Capital Management LLC increased its share by 26222.0 to have a control over 9.63 million shares. And Northern Trust Investments, Inc. raised its holdings to 1.35 million shares by acquiring 5.53 million shares or 1.23% of the stake.
Invesco Ltd (IVZ) concluded trading on 01/03/24 at a closing price of $17.27, with 4.09 million shares of worth about $70.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.31% during that period and on Wednesday the price saw a loss of about -2.70%. Currently the company’s common shares owned by public are about 454.80M shares, out of which, 440.18M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 17 analysts are covering the IVZ stock and their offered price forecasts bring an average price target of $15.84. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $20.00 and could fall to a lowest price of $13.00. The stock’s current price level is -9.03% below of average price target set by the analysts, while a dip to estimated low would result in loss of -32.85% for the stock. However, touching the estimated high of $20.00 would mean a gain of 13.65% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 64 times over the past 12 months. They bought 1,875,960 shares in 42 of the transactions. In 22 selling transactions, insiders dumped 8,527,161 shares.
Vanguard Total Stock Market ETF, Vanguard Small Cap Index Fund, and Vanguard 500 Index Fund are the top 3 mutual funds which are holding stakes in Invesco Ltd Vanguard Total Stock Market ETF is currently holding 13.76 million shares of worth totaling $196.36 million. The company recently came buying 0.13 million shares which brought its stake up to 3.06% of the company’s outstanding shares. Vanguard Small Cap Index Fund bought 49811.0 shares, after which its hold over company’s outstanding shares expand to 2.52%, leaving 11.34 million shares with the mutual fund that have a worth of about $161.83 million. Vanguard 500 Index Fund, after buying 10.58 million shares, have now control over 2.35% of the stake in the company. It holds 47732.0 shares of worth $150.97 million.
Invesco Ltd (NYSE: IVZ) started trading at $17.50, below -$0.25 from concluding price of the previous day. Stock saw a price change of -3.84% in past 5 days and over the past one month there was a price change of 16.22%. Year-to-date (YTD), IVZ shares are showing a performance of -3.20% which decreased to -4.00% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $12.48 but also hit the highest price of $20.56 during that period. The average intraday trading volume for Invesco Ltd shares is 5.58 million. The stock is currently trading 3.27% above its 20-day simple moving average (SMA20), while that difference is up 17.07% for SMA50 and it goes to 11.03% higher than SMA200.
Dimensional Fund Advisors LP acquired 11.21 million shares of Invesco Ltd having value of about $159.91 million. Data submitted at the U.S SEC by Dimensional Fund Advisors LP revealed that the firm now holds 1.64 million shares in the company valued at close to $28374454.57, or have control over 17.18% stake in the company. Invesco Ltd (NYSE: IVZ) currently have 454.80M outstanding shares and institutions hold larger chunk of about 86.22% of that. Holding of mutual funds in the company is about 38.32% while other institutional holders and individual stake holders have control over 48.69% and 30.42% of the stake respectively.
The stock has a current market capitalization of $7.76B and its 3Y-monthly beta is at 1.46. PE ratio of stock for trailing 12 months is 13.25, while it has posted earnings per share of $1.30 in the same period. Its PEG reads 2.16 while making debt-to-equity ratio of 0.56. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IVZ, volatility over the week remained 1.68% while standing at 2.41% over the month.
Analysts are in expectations that Invesco Ltd (IVZ) stock would likely to be making an EPS of $0.38 in the current quarter, while forecast for next quarter EPS is $0.35 and it is $1.63 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.33 which is $0.43 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.39 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -14.37% while it is estimated to increase by 12.88% in next year. EPS is likely to grow at an annualized rate of 6.14% for next 5-years, compared to annual growth of -11.55% made by the stock over the past 5-years.
Analysts at 17 brokerage firms have issued recommendations for the Invesco Ltd (IVZ)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.65. Out of those 17 Wall Street analysts, 3 recommended a “Buy” rating, while 14 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Keefe Bruyette on December 14, 2023 offering an Outperform rating for the stock and assigned a target price range of between $15.50 and $20 to it.
